Abstract
Background Wide variation between countries has been noted in per-capita mortality from the disease (COVID-19) caused by the SARS-CoV-2 virus. Determinants of this variation are not fully understood.
Methods Potential predictors of country-wide per-capita coronavirus-related mortality were examined, including age, sex ratio, obesity prevalence, temperature, urbanization, smoking, duration of infection, lockdowns, viral testing, contact tracing policies, and public mask-wearing norms and policies. Multivariable linear regression analysis was performed.
Results In univariate analyses, the prevalence of smoking, per-capita gross domestic product, urbanization, and colder average country temperature were positively associated with coronavirus-related mortality. In a multivariable analysis of 194 countries, the duration of infection in the country, and the proportion of the population 60 years of age or older were positively associated with per-capita mortality, while duration of mask-wearing by the public was negatively associated with mortality (all p<0.001). The prevalence of obesity was independently associated with mortality in models which controlled for testing levels or policy. International travel restrictions were independently associated with lower per-capita mortality, but other containment measures and viral testing and tracing policies were not. In countries with cultural norms or government policies supporting public mask-wearing, per-capita coronavirus mortality increased on average by just 9.0% each week, as compared with 47% each week in remaining countries. On multivariable analysis, lockdowns tended to be associated with less mortality (p=0.44), and increased per-capita testing with higher reported mortality (p=0.72), though neither association was statistically significant.
Conclusions Societal norms and government policies supporting the wearing of masks by the public, as well as international travel controls, are independently associated with lower per-capita mortality from COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Office of Research Subjects Protection at Virginia Commonwealth University.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
None of the authors has any conflicts of interest to disclose.
Data Availability
Data can be requested from the first author.
